3
Announcements
Trials
Browse
Landscape
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Pathologic Complete Response
1
Glioblastoma
1
Esophageal Squamous Cell Carcinoma
1
Esophageal Neoplasms
1
Adenocarcinoma Of Esophagus
1
Interventions
Trastuzumab
2
toripalimab
1
pyrotinib
1
Vinblastine
1
Transurethral Resection of Bladder
1
Thalidomide
1
TP protocol
1
Sodium Chloride
1
Radiotherapy, Intensity-Modulated
1
Radiotherapy
1
Positron Emission Tomography Computed Tomography
1
Paclitaxel
1
Neoadjuvant Therapy
1
Metformin
1
Magnetic Resonance Imaging
1
Immunohistochemistry
1
Esophagectomy
1
Endoscopy
1
Dynamic Contrast Enhanced Magnetic Resonance Imaging
1
Diffusion Magnetic Resonance Imaging
1
Dexamethasone
1
Decitabine
1
Cytarabine
1
Cisplatin
1
Chemoradiotherapy
1
Cell-Free Nucleic Acids
1
Carboplatin
1
Bortezomib
1
Blood Specimen Collection
1
Albumin-Bound Paclitaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Pathologic Complete Response
×
Dynamic Contrast Enhanced Magnetic Resonance Imaging
×
Clear all
NCT03474341
2020-11-16
PRIDE
UMC Utrecht
Unknown
200 enrolled